Inhaled chemotherapy in lung cancer: future concept of nanomedicine

Paul Zarogoulidis1, Ekaterini Chatzaki2, Konstantinos Porpodis1, Kalliopi Domvri1, Wolfgang Hohenforst-Schmidt3, Eugene P Goldberg4, Nikos Karamanos5, Konstantinos Zarogoulidis11Pulmonary Department, "G Papanikolaou" General Hospital, Aristotle University of Thessaloniki, G...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst-Schmidt W, Goldberg EP, Karamanos N, Zarogoulidis K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/8e464444fa464bd8a3a691fc788e73e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8e464444fa464bd8a3a691fc788e73e6
record_format dspace
spelling oai:doaj.org-article:8e464444fa464bd8a3a691fc788e73e62021-12-02T02:42:27ZInhaled chemotherapy in lung cancer: future concept of nanomedicine1176-91141178-2013https://doaj.org/article/8e464444fa464bd8a3a691fc788e73e62012-03-01T00:00:00Zhttp://www.dovepress.com/inhaled-chemotherapy-in-lung-cancer-future-concept-of-nanomedicine-a9541https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Paul Zarogoulidis1, Ekaterini Chatzaki2, Konstantinos Porpodis1, Kalliopi Domvri1, Wolfgang Hohenforst-Schmidt3, Eugene P Goldberg4, Nikos Karamanos5, Konstantinos Zarogoulidis11Pulmonary Department, "G Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Greece; 2Pharmacology Laboratory, Medical School, Democritus University of Thrace, Alexandroupolis, Greece; 3II Medical Clinic, Hospital Coburg, University of Wurzburg, Coburg, Germany; 4Biomaterials Science and Engineering, Department of Materials Science and Engineering, University of Florida, FL; 5Biochemistry Laboratory, Department of Chemistry, University of Patra, GreeceAbstract: Regional chemotherapy was first used for lung cancer 30 years ago. Since then, new methods of drug delivery and pharmaceuticals have been investigated in vitro, and in animals and humans. An extensive review of drug delivery systems, pharmaceuticals, patient monitoring, methods of enhancing inhaled drug deposition, safety and efficacy, and also additional applications of inhaled chemotherapy and its advantages and disadvantages are presented. Regional chemotherapy to the lung parenchyma for lung cancer is feasible and efficient. Safety depends on the chemotherapy agent delivered to the lungs and is dose-dependent and time-dependent. Further evaluation is needed to provide data regarding early lung cancer stages, and whether regional chemotherapy can be used as neoadjuvant or adjuvant treatment. Finally, inhaled chemotherapy could one day be administered at home with fewer systemic adverse effects.Keywords: inhaled chemotherapy, carriers, transducersZarogoulidis PChatzaki EPorpodis KDomvri KHohenforst-Schmidt WGoldberg EPKaramanos NZarogoulidis KDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 1551-1572 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Zarogoulidis P
Chatzaki E
Porpodis K
Domvri K
Hohenforst-Schmidt W
Goldberg EP
Karamanos N
Zarogoulidis K
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
description Paul Zarogoulidis1, Ekaterini Chatzaki2, Konstantinos Porpodis1, Kalliopi Domvri1, Wolfgang Hohenforst-Schmidt3, Eugene P Goldberg4, Nikos Karamanos5, Konstantinos Zarogoulidis11Pulmonary Department, "G Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Greece; 2Pharmacology Laboratory, Medical School, Democritus University of Thrace, Alexandroupolis, Greece; 3II Medical Clinic, Hospital Coburg, University of Wurzburg, Coburg, Germany; 4Biomaterials Science and Engineering, Department of Materials Science and Engineering, University of Florida, FL; 5Biochemistry Laboratory, Department of Chemistry, University of Patra, GreeceAbstract: Regional chemotherapy was first used for lung cancer 30 years ago. Since then, new methods of drug delivery and pharmaceuticals have been investigated in vitro, and in animals and humans. An extensive review of drug delivery systems, pharmaceuticals, patient monitoring, methods of enhancing inhaled drug deposition, safety and efficacy, and also additional applications of inhaled chemotherapy and its advantages and disadvantages are presented. Regional chemotherapy to the lung parenchyma for lung cancer is feasible and efficient. Safety depends on the chemotherapy agent delivered to the lungs and is dose-dependent and time-dependent. Further evaluation is needed to provide data regarding early lung cancer stages, and whether regional chemotherapy can be used as neoadjuvant or adjuvant treatment. Finally, inhaled chemotherapy could one day be administered at home with fewer systemic adverse effects.Keywords: inhaled chemotherapy, carriers, transducers
format article
author Zarogoulidis P
Chatzaki E
Porpodis K
Domvri K
Hohenforst-Schmidt W
Goldberg EP
Karamanos N
Zarogoulidis K
author_facet Zarogoulidis P
Chatzaki E
Porpodis K
Domvri K
Hohenforst-Schmidt W
Goldberg EP
Karamanos N
Zarogoulidis K
author_sort Zarogoulidis P
title Inhaled chemotherapy in lung cancer: future concept of nanomedicine
title_short Inhaled chemotherapy in lung cancer: future concept of nanomedicine
title_full Inhaled chemotherapy in lung cancer: future concept of nanomedicine
title_fullStr Inhaled chemotherapy in lung cancer: future concept of nanomedicine
title_full_unstemmed Inhaled chemotherapy in lung cancer: future concept of nanomedicine
title_sort inhaled chemotherapy in lung cancer: future concept of nanomedicine
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/8e464444fa464bd8a3a691fc788e73e6
work_keys_str_mv AT zarogoulidisp inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT chatzakie inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT porpodisk inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT domvrik inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT hohenforstschmidtw inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT goldbergep inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT karamanosn inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
AT zarogoulidisk inhaledchemotherapyinlungcancerfutureconceptofnanomedicine
_version_ 1718402233662439424